Literature DB >> 26243802

Enteric fever in a British soldier from Sierra Leone.

Lucy G Osborne1, M Brown2, M S Bailey3.   

Abstract

Enteric fever (typhoid and paratyphoid) remains a threat to British troops overseas and causes significant morbidity and mortality. We report the case of a soldier who developed typhoid despite appropriate vaccination and field hygiene measures, which began 23 days after returning from a deployment in Sierra Leone. The incubation period was longer than average, symptoms started 2 days after stopping doxycycline for malaria chemoprophylaxis and initial blood cultures were negative. The Salmonella enterica serovar Typhi eventually isolated was resistant to amoxicillin, co-amoxiclav, co-trimoxazole and nalidixic acid and had reduced susceptibility to ciprofloxacin. He was successfully treated with ceftriaxone followed by azithromycin, but 1 month later he remained fatigued and unable to work. The clinical and laboratory features of enteric fever are non-specific and the diagnosis should be considered in troops returning from an endemic area with a febrile illness. Multiple blood cultures and referral to a specialist unit may be required. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Diagnostic microbiology < INFECTIOUS DISEASES; Enteric fever; Military Personnel; Sierra Leone; Typhoid fever

Mesh:

Substances:

Year:  2015        PMID: 26243802     DOI: 10.1136/jramc-2015-000470

Source DB:  PubMed          Journal:  J R Army Med Corps        ISSN: 0035-8665            Impact factor:   1.285


  1 in total

1.  Laboratory-acquired infections of Salmonella enterica serotype Typhi in South Africa: phenotypic and genotypic analysis of isolates.

Authors:  Anthony Marius Smith; Shannon Lucrecia Smouse; Nomsa Pauline Tau; Colleen Bamford; Vineshree Mischka Moodley; Charlene Jacobs; Kerrigan Mary McCarthy; Adré Lourens; Karen Helena Keddy
Journal:  BMC Infect Dis       Date:  2017-09-29       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.